InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Myles David C., Directeur du Développement. Officer active across 1 companies, notably Olema Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €182k. The latest transaction was filed on 10 December 2021 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€91,20410,000 shares@ €9.12040.0077% mcap100.0% of flow
Common Stock
SEC:0001415889-21-005860·
€91,20410,000 shares@ €9.12040.0077% mcap50.0% of flow
Common Stock
SEC:0001415889-21-005860:0·
2 of 2 declarations
About Myles David C.
David C. Myles is the Chief Development Officer at Olema Pharmaceuticals, Inc. He is responsible for product development strategy and innovation. His role is crucial for the growth and success of the firm in the pharmaceutical sector.
